Drug-induced skin toxicity: gaps in preclinical testing cascade as opportunities for complex in vitro models and assays
The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Skin is the largest organ of the body and serves as the principle barrier to the environment. Composed of multiple cell types arranged in stratified layers with highly specialized appendages, it serves sensory and immune surveillance roles in addition to its primary mechanical function. Several complex in vitro models of skin (i.e. microphysiological systems (MPS) including but not limited to 3D tissues, organ-on-a-chip, organoids), have been developed and assays validated for regulatory purposes. As such, skin is arguably the most advanced organ with respect to model development and adoption across industries including chemical, cosmetic, and to a somewhat lesser extent, pharmaceutical. Early adoption of complex skin models and associated assays for assessment of irritation and corrosion spurred research into other areas such as sensitization, absorption, phototoxicity, and genotoxicity. Despite such considerable advancements, opportunities remain for immune capabilities, inclusion of appendages such as hair follicles, fluidics, and innervation, among others. Herein, we provide an overview of current complex skin model capabilities and limitations within the drug development scheme, and recommendations for future model development and assay qualification and/or validation with the intent to facilitate wider adoption of use within the pharmaceutical industry.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These consortia not only promote MPS and OoC adoption but also generate lists of reference compounds relevant to various organ systems (Ainslie et al., 2019; Baudy et al., 2020; Hardwick et al., 2020; Peters et al., 2020; Phillips et al., 2020; Pointon et al., 2021).”
From Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip (2024) · cites this paper as Hardwick et al., 2020
Citations
Cites
Visualization and analysis of gene expression in tissue sections by spatial transcriptomics
Ståhl, P. L., Salmén, F., Vickovic, S., Lundmark, A., Navarro, J. F., Magnusson, J., Giacomello, S., Asp, M., Westholm, J. O., Huss, M., et al. (2016) · Science · doi:10.1126/science.aaf2403 · Cited by 3,834
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Michot, J. M., Bigenwald, C., Champiat, S., Collins, M., Carbonnel, F., Postel-Vinay, S., Berdelou, A., Varga, A., Bahleda, R., Hollebecque, A., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2015.11.016 · Cited by 2,127
Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones
JANCSÓ, G., KIRALY, E., & JANCSÓ-GÁBOR, A. (1977) · Nature · doi:10.1038/270741a0 · Cited by 1,282
Cytokine modulation of atopic dermatitis filaggrin skin expression
Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L., Beck, L. A., Barnes, K. C., & Leung, D. Y. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.04.031 · Cited by 1,084
Casarett and Doull's Toxicology: The Basic Science of Poisons
TIMBRELL, J. A. (1981) · Biochemical Society Transactions · doi:10.1042/bst0090255a · Cited by 875
Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
Illing, P. T., Vivian, J. P., Dudek, N. L., Kostenko, L., Chen, Z., Bharadwaj, M., Miles, J. J., Kjer-Nielsen, L., Gras, S., Williamson, N. A., et al. (2012) · Nature · doi:10.1038/nature11147 · Cited by 696
Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6
Kim, B. E., Leung, D. Y. M., Boguniewicz, M., & Howell, M. D. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.11.006 · Cited by 538
Globally Harmonized System of Classification and Labelling of Chemicals (GHS)
(2016) · Globally harmonized system of classification and labelling of chemicals · doi:10.18356/a6a925c3-en · Cited by 511
Cottrez, F., Boitel, E., Ourlin, J.-C., Peiffer, J.-L., Fabre, I., Henaoui, I.-S., Mari, B., Vallauri, A., Paquet, A., Barbry, P., et al. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.01.007 · Cited by 499
Significance of Skin Barrier Dysfunction in Atopic Dermatitis
Kim, B. E., & Leung, D. Y. M. (2018) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2018.10.3.207 · Cited by 393
Research works printed but not linked: 17
- Abd, 2016, J. Clin. Pharmacol., 8, 163
- OECD , Explanatory background document to the OECD draft Test Guideline on in vitro skin irritation testing , 2010
- G. F. Gerberick , J. A.Troutman , L. M.Foertsch and P. S.Kern , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 225–233
- A. Natsh , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 235–248
- E. Corsini and V.Galbiati , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 263–272
- T. Ramirez , A.Mehling and R.Landsiedel , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 249–262
- D. Keller , C.Bauch and P.Patel , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Spinger Cham , 2017 , pp. 377–391
- H. Sakaguchi and T.Ashikaga , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 289–309
- N. Alepee , C.Piroird and L.Nardelli , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Spinger Cham , 2017 , pp. 311–330
- M. Lindstedt , K. S.Zeller , H.Johansson and C.Borrebaeck , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 393–403
- N. Lambrechts , G.Schoeters , R.Van Den Heuvel , H.Witters , I.Nelissen and J.Hooyberghs , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 347–359
- P. R. Esser and S. F.Martin , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 449–454
- S. Pfuhler and K.Reisinger , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 513–525
- K. Reisinger and S.Pfuhler , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 527–539
- H. Kandarova and M.Liebsch , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 483–503
- H. Kojima , K.Hosoi and S.Onoue , in Alternatives for Dermal Toxicity Testing , ed. C. Eskes , E. Van Vliet and H. I. Maibach , Springer Cham , 2017 , pp. 477–482
- Coimbra, 2015, Ann. Transl. Med., 3, 76
Cited by
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029
Organ-on-a-chip meets artificial intelligence in drug evaluation
Deng, S., Li, C., Cao, J., Cui, Z., Du, J., Fu, Z., Yang, H., & Chen, P. (2023) · Theranostics · doi:10.7150/thno.87266 · Cited by 260
Marx, U. (2020) · ALTEX · doi:10.14573/altex.2001241 · Cited by 218
“Members of the IQ Consortium recently published two manuscripts with recommendations for in vitro model development and assay qualification of lung and skin models to facilitate their wider adoption of use within the pharmaceutical industry (Ainslie et al., 2019; Hardwick et al. 2019).”
MethodKohl, Y., Rundén‐Pran, E., Mariussen, E., Hesler, M., Yamani, N. E., Longhin, E., & Dušinská, M. (2020) · Nanomaterials · doi:10.3390/nano10101911 · Cited by 123
Fabre, K., Berridge, B., Proctor, W. R., Ralston, S., Will, Y., Baran, S. W., Yoder, G., & Van Vleet, T. R. (2020) · Lab on a Chip · doi:10.1039/c9lc01168d · Cited by 116
Self-citation
Metadata
- Authors
- Hardwick, R. N., Betts, C. J., Whritenour, J., Sura, R., Thamsen, M., Kaufman, E. H., & Fabre, K.
- Affiliations
- Theravance Biopharma (United States) (US)
- AstraZeneca (United Kingdom) (GB)
- Pfizer (United States) (US)
- AbbVie (United States) (US)
- Corresponding author
- Hardwick, Rhiannon N.
- Venue
- Lab on a Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 20
- Issue
- 2
- Pages
- 199-214
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- OpenAlex
- W2979806580
- Cited by
- 48
- References
- 73
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 5 · 2021: 10 · 2020: 4
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- drug-induced skin toxicity, microphysiological systems, organ-on-a-chip, skin organoids, skin irritation, skin corrosion, skin sensitization, percutaneous absorption, phototoxicity, genotoxicity, hair follicle, innervation, drug development
- MeSH terms
- Drug Development, Animals, Drug Industry, Pharmaceutical Preparations, Humans, Models, Biological, Skin, Lab-On-A-Chip Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.